Results 21 to 30 of about 24,741 (161)

Risk of flare in juvenile idiopathic arthritis: Is it related to the methotrexate treatment strategy or patient characteristics?

open access: yesThe Turkish Journal of Gastroenterology, 2023
Objectives: The study aimed to determine the factors that increase the risk of disease flare in patients with juvenile idiopathic arthritis who stopped methotrexate (MTX) monotherapy following inactive disease (ID).
Rana İşgüder   +5 more
doaj  

EFFICACY OF ETANERCEPT IN TREATMENT OF VARIOUS TYPES OF JUVENILE IDIOPATHIC ARTHRITIS

open access: yesВопросы современной педиатрии, 2013
Aim: to assess efficacy and safety of etanercept in treatment of various types of juvenile idiopathic arthritis in children under conditions of real clinical practice.
O. Yu. Konopel'ko   +5 more
doaj   +1 more source

Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset

open access: yesClinics, 2011
OBJECTIVE: To assess clinical and laboratory features that differentiate acute lymphoblastic leukemia from systemic juvenile idiopathic arthritis at disease onset. METHODS: Fifty-seven leukemia patients with musculoskeletal involvement, without blasts on
Mirian S. Tamashiro   +5 more
doaj   +1 more source

Whole exome sequencing in a juvenile idiopathic arthritis large family with SERPINA1 gene mutations

open access: yesBMC Rheumatology, 2022
Objectives Although the underlying mechanisms and mediators of arthritis in juvenile idiopathic arthritis are not well understood, accumulated evidence supports the mixt role of genetic and environmental factors.
Cyprian Popescu
doaj   +1 more source

Clinical manifestations of gastrointestinal tract changes in children with juvenile idiopathic arthritis

open access: yesАктуальні проблеми сучасної медицини, 2021
Summary. Juvenile idiopathic arthritis remains one of the most common chronic inflammatory rheumatic diseases of childhood. A significant proportion of patients experience nausea, vomiting, abdominal pain and loss of appetite with methotrexate therapy ...
Natalia Shevchenko   +2 more
doaj   +1 more source

Cytokine status and hemostasis disorders in children with juvenile idiopathic arthritis

open access: yesActa Biomedica Scientifica
Juvenile idiopathic arthritis is a chronic inflammatory joint disease in children under 16 years of age associated with pathological immune response to various antigens. Probable factors are infectious and immunogenetic.
M. V. Gomellya   +3 more
doaj   +1 more source

Progressive pseudorheumatoid dysplasia misdiagnosed as juvenile idiopathic arthritis: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Progressive pseudorheumatoid dysplasia is a rare, autosomal recessively inherited, noninflammatory musculoskeletal disorder caused by mutations occurring in the WNT1-inducible signaling pathway protein 3 gene.
Anjumanara Anver Omar   +4 more
doaj   +1 more source

THE ROLE OF APOPTOSIS VIOLATIONS IN THE JUVENILE IDIOPATHIC ARTHRITIS FORMATION

open access: yesПедиатрическая фармакология, 2012
We investigated the polymorphism of the gene p53 exon 4 Arg72Pro and intron 3 ins/del 16 b. p. in children with juvenile idiopathic arthritis in order to identify the influence of gene polymorphisms on the course and outcome of the disease.
A. N. Kozhevnikov   +4 more
doaj   +1 more source

Juvenile idiopathic arthritis in infants with Harlequin Ichthyosis: two cases report and literature review

open access: yesItalian Journal of Pediatrics, 2020
Background Harlequin Ichthyosis is the most severe variant of congenital autosomal recessive ichthyosis, associated with severe morbidity and potentially lethal in early life.
Cinzia Auriti   +8 more
doaj   +1 more source

Systemic juvenile idiopathic arthritis complicated by hemophagocytic syndrome

open access: yesКлинический разбор в общей медицине
Systemic juvenile idiopathic arthritis is a polygenic autoinflammatory disease. Pronounced systemic clinical manifestations, a significant increase in the level of inflammatory markers and the absence of autoantibodies distinguish this disease from other
Natalya A. Belykh   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy